![L1 : les dates de la saison 2021-2022 sont connues - actu Girondins de Bordeaux par WebGirondins, FCGB : Mercato infos et Transferts depuis 2001 avec le 1er e média indépendant sur les Girondins L1 : les dates de la saison 2021-2022 sont connues - actu Girondins de Bordeaux par WebGirondins, FCGB : Mercato infos et Transferts depuis 2001 avec le 1er e média indépendant sur les Girondins](https://www.webgirondins.com/cache/images/671_c7e3aa1653918006910860be7efab606.png)
L1 : les dates de la saison 2021-2022 sont connues - actu Girondins de Bordeaux par WebGirondins, FCGB : Mercato infos et Transferts depuis 2001 avec le 1er e média indépendant sur les Girondins
![PSG's players celebrates their club's tenth Ligue 1 title during the 2021-2022 Ligue 1 championship trophy ceremony following the French L1 football match between Paris Saint-Germain (PSG) and Metz at the Parc PSG's players celebrates their club's tenth Ligue 1 title during the 2021-2022 Ligue 1 championship trophy ceremony following the French L1 football match between Paris Saint-Germain (PSG) and Metz at the Parc](https://c8.alamy.com/comp/2J9GBYF/psgs-players-celebrates-their-clubs-tenth-ligue-1-title-during-the-2021-2022-ligue-1-championship-trophy-ceremony-following-the-french-l1-football-match-between-paris-saint-germain-psg-and-metz-at-the-parc-des-princes-stadium-in-paris-on-may-21-2022-photo-by-christian-liewigabacapresscom-2J9GBYF.jpg)
PSG's players celebrates their club's tenth Ligue 1 title during the 2021-2022 Ligue 1 championship trophy ceremony following the French L1 football match between Paris Saint-Germain (PSG) and Metz at the Parc
![Envafolimab, The PD-L1 Antibody Approved by NMPA! 3DMed Partners with Alphamab Oncology and Simcere to Innovate Immunotherapy Envafolimab, The PD-L1 Antibody Approved by NMPA! 3DMed Partners with Alphamab Oncology and Simcere to Innovate Immunotherapy](https://en.3d-medicines.com/upload/images/202111260058057274.png)
Envafolimab, The PD-L1 Antibody Approved by NMPA! 3DMed Partners with Alphamab Oncology and Simcere to Innovate Immunotherapy
![CheckMate 9LA Combination Effective in Advanced NSCLC Despite PD-L1 Expression, TMB Status - ILCN.org (ILCN/WCLC) CheckMate 9LA Combination Effective in Advanced NSCLC Despite PD-L1 Expression, TMB Status - ILCN.org (ILCN/WCLC)](https://www.ilcn.org/wp-content/uploads/2021/12/ESMO-ELCC21-1620x912px.jpg)